BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The BioCalendar - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The BioCalendar
X-ORIGINAL-URL:https://thebiocalendar.com
X-WR-CALDESC:Events for The BioCalendar
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20250309T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20251102T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20260308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20261101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20270314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20271107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260413
DTEND;VALUE=DATE:20260417
DTSTAMP:20260415T015255
CREATED:20260109T153145Z
LAST-MODIFIED:20260109T153146Z
UID:9756-1776038400-1776383999@thebiocalendar.com
SUMMARY:Drug Discovery Chemistry
DESCRIPTION:Drug Discovery Chemistry is a dynamic conference for medicinal\, biophysical\, and computational chemists working across pharma\, biotech\, and academia. Focused on discovery and optimization challenges of small-molecule and macrocyclic drug candidates\, the 2026 event features new sessions spanning AI- and ML-driven design\, fragment- and structure-based discovery\, molecular glues and degraders\, DNA-encoded libraries\, and emerging biophysical tools. Attendees can tailor their experience by exploring concurrent tracks covering today’s most innovative approaches to drug discovery.
URL:https://thebiocalendar.com/event/drug-discovery-chemistry-2/
LOCATION:San Diego\, San Diego\, CA\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260414
DTEND;VALUE=DATE:20260416
DTSTAMP:20260415T015255
CREATED:20251125T143235Z
LAST-MODIFIED:20251125T143235Z
UID:9584-1776124800-1776297599@thebiocalendar.com
SUMMARY:American Biomanufacturing Summit
DESCRIPTION:The Generis American Biomanufacturing Summit (BIO) has a strong reputation as the leading platform for connecting senior leaders and exchanging ideas in the biopharma and biotech industries. This two-day conference is designed to bring together biopharma executives and solution providers to discuss emerging trends\, strategic insights\, and best practices in an ever-evolving biomanufacturing landscape. Join over 350 biopharma and biotech executive leaders\, including more than 50 speakers\, 150 senior-level attendees\, and hundreds of participants from solution companies at this annual event as we explore the latest challenges\, opportunities\, and innovations shaping the industry. With sessions led by top biotech executives\, the agenda will dive into critical topics such as AAV manufacturing\, cell and gene therapy\, capacity management\, quality assurance and control\, regulatory compliance\, operational excellence\, and supply chain and logistics. Network with fellow biopharma leaders and connect with leading solution providers as we uncover strategies to maximize efficiency and ensure compliance within the biomanufacturing space.
URL:https://thebiocalendar.com/event/american-biomanufacturing-summit/
LOCATION:San Francisco\, CA\, San Francisco\, CA\, United States
CATEGORIES:Summit
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260415T110000
DTEND;TZID=America/Los_Angeles:20260415T120000
DTSTAMP:20260415T015255
CREATED:20260318T143414Z
LAST-MODIFIED:20260318T143414Z
UID:10029-1776250800-1776254400@thebiocalendar.com
SUMMARY:Less Risk\, More Speed -The New Blueprint for Bioconjugate Development: A Fireside Chat
DESCRIPTION:Join this webinar to learn how an integrated CDMO+CRO model is transforming bioconjugate development by reducing risk and accelerating timelines from discovery to GMP supply. Discover actionable strategies and real-world insights to streamline your ADC and biologics programs while avoiding costly delays and late-stage failures. \nYou’ll leave with insights on:\n– How an integrated development model reduces technical & operational risk across next-gen modalities\n– Early development strategies that front-load risk identification & mitigation before it becomes costly\n– Partner and technology selection criteria — what to look for and what to avoid\n– Navigating the evolving regulatory landscape for novel bioconjugate modalities\n– Fast-track execution strategies that compress the discovery-to-GMP timeline without compromising quality
URL:https://thebiocalendar.com/event/less-risk-more-speed-the-new-blueprint-for-bioconjugate-development-a-fireside-chat/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/04-15-26-Abzena-Eblast-700x200-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20260415T110000
DTEND;TZID=America/Los_Angeles:20260415T120000
DTSTAMP:20260415T015255
CREATED:20260319T135546Z
LAST-MODIFIED:20260319T135546Z
UID:10041-1776250800-1776254400@thebiocalendar.com
SUMMARY:OneTeam™: Setting a New Standard for Biotech Program Visibility
DESCRIPTION:Learn how to transform your gene therapy program management by adopting the OneTeam™ approach to create a transparent\, integrated “single source of truth” that replaces fragmented reporting and improves decision-making. Explore how enhanced visibility\, standardized governance\, and a shared digital interface can strengthen sponsor-CDMO collaboration and turn outsourcing from a black box into a streamlined\, confident partnership.
URL:https://thebiocalendar.com/event/oneteam-setting-a-new-standard-for-biotech-program-visibility/
ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/03/04-15-26-Andelyn-eBlast-700x200-1.png
END:VEVENT
END:VCALENDAR